BDX vs BAX vs SKYA Stock Comparison

Becton Dickinson, Baxter International and SkyAI Prices as of Oct 29, 2026 Peers: Industry group
1 more company in this comparison (MDLN) Create a free account to keep reading and compare up to 10 companies.
BDX Becton Dickinson & Co
$198.32 +8.9% 1M +9.3% 1Y
Market cap
$54.28B
P/E
57.7x
Revenue (TTM)
$23.25B
Div. yield
–
Medical Supplies Healthcare
8 wins
SKYA SkyAI, Inc.
$2.93 +60.1% 1M -40.9% 1Y
Market cap
$214.84M
P/E
–
Revenue (TTM)
$194.22K
Div. yield
–
Medical Supplies Healthcare
2 wins

Head to Head

10 decided of 12

Becton Dickinson leads on 8 of the 12 questions below (Becton Dickinson 8, SkyAI 2). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionBDXBAXSKYALeader
Larger companyMarket capitalisation $54.28B $11.81B $214.84M BDX
Cheaper on earningsLower P/E, profitable companies only 57.7x -16.3x -0.7x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS 15.3x 11.9x 0.0x SKYA
Faster revenue growthRevenue growth, trailing twelve months +17.4% +5.3% +108.9% SKYA
More profitableNet margin, trailing twelve months 4.0% -6.2% -158,431.4% BDX
Better return on capitalReturn on invested capital 5.3% -1.4% — BDX
Less leveragedLower net debt / EBITDA 3.2x 9.0x — BDX
Higher dividend yieldTrailing dividend yield 0.00% 0.01% 0.00% –
Better 1-year returnPrice return, last 12 months +9.3% +4.8% -40.9% BDX
Better 5-year returnAnnualised price return, 5 years -3.7%/yr -21.5%/yr — BDX
Less volatileAnnualised volatility, 1 year 31.8% 45.1% 105.8% BDX
Higher overall scoreMean of the five percentile scores vs peers 68/100 44/100 26/100 BDX

Percentile Scorecard

BDXBAXSKYA

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisBDXBAXSKYA
Valuation 90 #23 of 227 89 #25 of 227 2 #222 of 227
Growth 48 #114 of 218 14 #187 of 218 7 #203 of 218
Profitability 80 #42 of 202 66 #69 of 202 1 #200 of 202
Financial Health 28 #168 of 233 19 #189 of 233 94 #14 of 233
Shareholder Returns 95 #8 of 130 33 #87 of 130 –
Overall 68 44 26
  • BDX ranked among 247 companies in Medical Devices and Diagnostics
  • BAX ranked among 247 companies in Medical Devices and Diagnostics
  • SKYA ranked among 247 companies in Medical Devices and Diagnostics

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodBDXBAXSKYASPY
1 month +8.9%0.0%+60.1% +0.7%
3 months +19.8%-12.2%+118.7% +3.7%
6 months +33.1%+33.6%+64.1% +7.1%
Year to date +2.2%+22.9%+44.3% +12.8%
1 year +9.3%+4.8%-40.9% +11.9%
3 years -21.0%-26.7%-99.9% +85.2%
3 years, per year -7.6%-9.8%-90.2% +22.8%
5 years -17.2%-70.3%— +67.6%
5 years, per year -3.7%-21.5%— +10.9%
10 years +18.2%-50.2%— +262.0%
10 years, per year +1.7%-6.7%— +13.7%

Risk

MeasureBDXBAXSKYASPY
Volatility, 1Y 31.8%45.1%105.8% 12.7%
Downside volatility, 1Y 33.1%49.5%104.6% 12.6%
Beta vs S&P 500, 1Y 0.331.182.59 1.00
Return / volatility, 1Y 0.290.11-0.39 0.94
Max drawdown, 5Y -50.4%-82.3%-100.0% -25.4%
From 52-week high -5.6%-17.1%-40.9% -1.2%
52-week high $210.02$28.35$4.96 $779.14
52-week low $140.71$15.80$0.95 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleBDXBAXSKYA
P/E now vs peer median 57.9xmedian 28.7x -16.8xmedian 28.7x -0.7xmedian 28.7x
P/S now vs peer median 2.3xmedian 3.0x 1.0xmedian 3.0x 1,088xmedian 3.0x
EV/EBITDA now vs peer median 14.1xmedian 17.8x 25.6xmedian 17.8x —median 17.8x
P/FCF now vs peer median 16.9xmedian 26.4x 10.5xmedian 26.4x —median 26.4x
P/B now vs peer median 2.2xmedian 2.4x 1.9xmedian 2.4x 1.3xmedian 2.4x
PEG now vs peer median -3.97median 0.99 0.53median 0.99 0.01median 0.99

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsBDXBAXSKYA
Revenue $23.25B $11.61B $194.22K
Gross profit $10.91B $3.49B $321.93K
Operating income $2.48B -$221.00M -$289.52M
Net income $941.00M -$723.00M -$307.71M
Free cash flow $3.20B $1.16B –
R&D $1.37B $519.00M $399.91K
EPS (diluted) $3.42 $-1.39 $-4.27
Cash & equivalents $708.00M $1.98B $12.07M
Total debt $72.81B $8.60B –
Shares (diluted) 275.16M 520.00M 72.09M
Enterprise value $51.43B $3.69B $173.54M

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricBDXBAXSKYA
P/E 57.9x -16.8x -0.7x
P/FCF 16.9x 10.5x –
P/Operating cash flow 13.7x 7.3x –
P/S 2.3x 1.0x 1,088x
P/B 2.2x 1.9x 1.3x
P/Tangible book 2.3x 4.7x 16.3x
EV/EBITDA 14.1x 25.6x –
EV/EBIT 28.3x -84.9x -0.7x
EV/Revenue 3.0x 1.6x 1,025x
EV/FCF 21.9x 16.2x –
EV/Operating cash flow 17.7x 11.3x –
PEG (3Y EPS CAGR) -3.97 0.53 0.01

Growth

14 metrics
MetricBDXBAXSKYA
Revenue growth (1Y) 17.4% 5.3% 108.9%
Revenue CAGR (3Y) 6.9% 0.7% 23.8%
Gross profit growth (1Y) 23.7% -7.1% –
Gross profit CAGR (3Y) 8.5% -7.7% –
Operating income growth (1Y) 13.0% -136.3% -5,525%
Operating income CAGR (3Y) 3.3% 4.2% -212.8%
Net income growth (1Y) -40.6% -112.0% -42,440%
Net income CAGR (3Y) -17.3% -31.6% -238.0%
EPS growth (1Y) -38.0% -109.6% -487.2%
EPS CAGR (3Y) -14.6% -31.5% -84.2%
Operating cash flow growth (1Y) 43.5% 97.4% –
Operating cash flow CAGR (3Y) 14.5% 0.6% –
Free cash flow growth (1Y) 54.2% 243.5% –
Free cash flow CAGR (3Y) 22.5% -5.0% –

Profitability

14 metrics
MetricBDXBAXSKYA
Gross margin 46.9% 30.1% 165.8%
EBITDA margin 21.4% 6.3% –
Operating margin 10.7% -1.9% -149,065%
Pretax margin 8.4% -1.6% -151,352%
Net margin 4.0% -6.2% -158,431%
FCF margin 13.8% 10.0% –
Operating cash flow margin 17.0% 14.3% –
Return on equity 3.9% -11.4% -140.2%
Return on assets 1.9% -3.7% -137.6%
Return on invested capital 5.3% -1.4% –
Return on capital employed 6.0% -1.4% -136.7%
Asset turnover 0.5x 0.6x 0.0x
Cash conversion (OCF / net income) 4.2x -2.3x –
Stock comp / revenue 1.2% 0.9% 48,037%

Financial Health

11 metrics
MetricBDXBAXSKYA
Debt / assets 33.1% 44.3% –
Debt / equity 0.7x 1.3x –
Net debt / EBITDA 3.2x 9.0x –
Debt / FCF 5.2x 7.4x –
Liabilities / assets 51.9% 66.5% 1.9%
Equity / assets 48.1% 33.5% 98.1%
Interest coverage 4.2x – –
Current ratio 0.9x 1.8x 5.3x
Quick ratio 0.3x 1.0x 4.4x
Cash ratio 0.1x 0.5x 4.2x
Altman Z-score 2.30 2.33 31.69

Shareholder Returns

7 metrics
MetricBDXBAXSKYA
Dividend yield 2.1% 0.2% –
Net buyback yield 4.6% -0.2% –
Shareholder yield 6.7% 0.0% –
Payout ratio (earnings) – -14.1% –
Payout ratio (FCF) – 8.8% –
Dividend growth (1Y) – -75.0% –
Dividend CAGR (3Y) – -44.1% –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusBDXBAXSKYA
Forward P/E 15.3xFY2026 11.9xFY2026 0.0xFY2026
EPS, next fiscal year $12.99FY2026 $1.98FY2026 $2,362.06FY2026
EPS growth, next FY +14.8%FY2026 -10.4%FY2026 –
EPS growth, the year after -2.9% -3.5% –
Revenue, next fiscal year $18.11BFY2026 $11.05BFY2026 $70.01MFY2026
Revenue growth, next FY -17.1%FY2026 -1.7%FY2026 +34,200.1%FY2026
Revenue growth, the year after +11.6% +11.7% +17.5%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersBDXBAXSKYA
Held by institutions 96.1% 100.0% –
Institutions holding 1,443 691 –
Change in shares held, QoQ +0.6% +5.2% –
Institutions buying 688 359 –
Institutions selling 544 193 –
Buyers to sellers 1.26 1.86 –

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

BDXBAXSKYA
BDX 1.00 0.39 0.11
BAX 0.39 1.00 0.08
SKYA 0.11 0.08 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, BDX, BAX and SKYA?

Becton Dickinson (BDX) is the largest by market capitalisation: Becton Dickinson (BDX) $54.28B, Baxter International (BAX) $11.81B, SkyAI (SKYA) $214.84M.

Which company is growing faster?

SkyAI (SKYA) grew revenue fastest over the trailing twelve months: Becton Dickinson (BDX) +17.4%, Baxter International (BAX) +5.3%, SkyAI (SKYA) +108.9%.

Which company is more profitable?

Becton Dickinson (BDX) has the highest net margin (Becton Dickinson (BDX) 4.0%, Baxter International (BAX) -6.2%, SkyAI (SKYA) -158,431.4%). On return on invested capital, Becton Dickinson (BDX) leads (Becton Dickinson (BDX) 5.3%, Baxter International (BAX) -1.4%).

Which stock has performed better?

Over the past year Becton Dickinson (BDX) returned the most: Becton Dickinson (BDX) +9.3%, Baxter International (BAX) +4.8%, SkyAI (SKYA) -40.9%. Over five years, Becton Dickinson (BDX) compounded fastest (Becton Dickinson (BDX) -3.7%/yr, Baxter International (BAX) -21.5%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Only one of these companies pays a dividend: Becton Dickinson (BDX) 0.00%, Baxter International (BAX) 0.01%, SkyAI (SKYA) 0.00%. Becton Dickinson (BDX) and SkyAI (SKYA) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Becton Dickinson (BDX) has been the steadiest (Becton Dickinson (BDX) 31.8%, Baxter International (BAX) 45.1%, SkyAI (SKYA) 105.8%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, BDX, BAX and SKYA?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Becton Dickinson (BDX) leads on 8. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.